178 related articles for article (PubMed ID: 21431877)
1. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.
Pellegrini A; Carrera-Silva EA; Arocena A; Cano RC; Aoki MP; Gea S
Med Microbiol Immunol; 2011 Nov; 200(4):209-18. PubMed ID: 21431877
[TBL] [Abstract][Full Text] [Related]
2. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice.
Guiñazú N; Pellegrini A; Giordanengo L; Aoki MP; Rivarola HW; Cano R; Rodrigues MM; Gea S
Microbes Infect; 2004 Nov; 6(14):1250-8. PubMed ID: 15555530
[TBL] [Abstract][Full Text] [Related]
3. A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins.
Leon JS; Daniels MD; Toriello KM; Wang K; Engman DM
Infect Immun; 2004 Jun; 72(6):3410-7. PubMed ID: 15155647
[TBL] [Abstract][Full Text] [Related]
4. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
5. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide.
Zuñiga E; Motran CC; Montes CL; Yagita H; Gruppi A
J Immunol; 2002 Apr; 168(8):3965-73. PubMed ID: 11937553
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
Gironès N; Cuervo H; Fresno M
Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
10. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.
Giordanengo L; Maldonado C; Rivarola HW; Iosa D; Girones N; Fresno M; Gea S
Eur J Immunol; 2000 Nov; 30(11):3181-9. PubMed ID: 11093133
[TBL] [Abstract][Full Text] [Related]
11. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
[TBL] [Abstract][Full Text] [Related]
12. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
[TBL] [Abstract][Full Text] [Related]
13. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
14. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
15. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
16. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
Bryan MA; Guyach SE; Norris KA
PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
[TBL] [Abstract][Full Text] [Related]
18. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
[TBL] [Abstract][Full Text] [Related]
19. Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes.
Aoki MP; Guiñazú NL; Pellegrini AV; Gotoh T; Masih DT; Gea S
Am J Physiol Cell Physiol; 2004 Feb; 286(2):C206-12. PubMed ID: 13679306
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
Pereira VR; Lorena VM; Nakazawa M; Luna CF; Silva ED; Ferreira AG; Krieger MA; Goldenberg S; Soares MB; Coutinho EM; Correa-Oliveira R; Gomes YM
Parasitol Res; 2005 Jun; 96(3):154-61. PubMed ID: 15856302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]